Journal Home > Volume 1 , Issue 2–4

Full text
About this article

Current challenges and potential directions towards nanotechnology in medicine and transformation

Show Author's information Qianqian Ni1,2,3 ( )Xiaoyuan Chen1,2,3,4( )
Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119074, Singapore
Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore
Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore
Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A*STAR) 61 Biopolis Drive, Proteos, Singapore 138673, Singapore



Chen, H. M.; Zhang, W. Z.; Zhu, G. Z.; Xie, J.; Chen, X. Y. Rethinking Cancer Nanotheranostics. Nat. Rev. Mater. 2017, 2, 7024.


Auría-Soro, C.; Nesma, T.; Juanes-Velasco, P.; Landeira-Viñuela, A.; Fidalgo-Gomez, H.; Acebes-Fernandez, V.; Gongora, R.; Almendral Parra, M. J.; Manzano-Roman, R.; Fuentes, M. Interactions of Nanoparticles and Biosystems: Microenvironment of Nanoparticles and Biomolecules in Nanomedicine. Nanomaterials 2019, 9, 1365.


Fries, C. N.; Curvino, E. J.; Chen, J. L.; Permar, S. R.; Fouda, G. G.; Collier, J. H. Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health. Nat. Nanotechnol. 2021, 16, 1–14.


Irvine, D. J.; Dane, E. L. Enhancing cancer immunotherapy with nanomedicine. Nat. Rev. Immunol. 2020, 20, 321–334.


Chen, W.; Schilperoort, M.; Cao, Y. H.; Shi, J. J.; Tabas, I.; Tao, W. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis. Nat. Rev. Cardiol. 2022, 19, 228–249.


Musunuru, K.; Chadwick, A. C.; Mizoguchi, T.; Garcia, S. P.; DeNizio, J. E.; Reiss, C. W.; Wang, K.; Iyer, S.; Dutta, C.; Clendaniel, V. et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature 2021, 593, 429–434.


Barbier, A. J.; Jiang, A. Y.; Zhang, P.; Wooster, R.; Anderson, D. G. The clinical progress of MRNA vaccines and immunotherapies. Nat. Biotechnol. 2022, 40, 840–854.


Bhatia, S. N.; Chen, X. Y.; Dobrovolskaia, M. A.; Lammers, T. Cancer nanomedicine. Nat. Rev. Cancer 2022, 22, 550–556.


Boehnke, N.; Straehla, J. P.; Safford, H. C.; Kocak, M.; Rees, M. G.; Ronan, M.; Rosenberg, D.; Adelmann, C. H.; Chivukula, R. R.; Nabar, N. et al. Massively parallel pooled screening reveals genomic determinants of nanoparticle delivery. Science 2022, 377, eabm5551.


Dobrowolski, C.; Paunovska, K.; Schrader Echeverri, E.; Loughrey, D.; Da Silva Sanchez, A. J.; Ni, H. Z.; Hatit, M. Z. C.; Lokugamage, M. P.; Kuzminich, Y.; Peck, H. E. et al. Nanoparticle single-cell multiomic readouts reveal that cell heterogeneity influences lipid nanoparticle-mediated messenger RNA delivery. Nat. Nanotechnol. 2022, 17, 871–879.


Sago, C. D.; Lokugamage, M. P.; Paunovska, K.; Vanover, D. A.; Monaco, C. M.; Shah, N. N.; Gamboa Castro, M.; Anderson, S. E.; Rudoltz, T. G.; Lando, G. N. et al. High-throughput in vivo screen of functional MRNA delivery identifies nanoparticles for endothelial cell gene editing. Proc. Natl. Acad. Sci. USA 2018, 115, E9944–E9952.


Horejs, C. Organ chips, organoids and the animal testing conundrum. Nat. Rev. Mater. 2021, 6, 372–373.

Publication history
Rights and permissions

Publication history

Received: 20 November 2022
Accepted: 21 November 2022
Published: 08 December 2022
Issue date: December 2022


© The Author(s) 2022. Nano TransMed published by Tsinghua University Press.

Rights and permissions

The articles published in this open access journal are distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.